Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
ROSG [NASD]
Rosetta Genomics, Ltd.
Index- P/E- EPS (ttm)-14.55 Insider Own- Shs Outstand9.10M Perf Week17.94%
Market Cap36.49M Forward P/E- EPS next Y-1.09 Insider Trans- Shs Float9.09M Perf Month16.57%
Income-7.39M PEG- EPS next Q-0.28 Inst Own6.13% Short Float17.71% Perf Quarter-11.28%
Sales0.10M P/S364.91 EPS this Y68.18% Inst Trans-9.71% Short Ratio6.18 Perf Half Y-6.09%
Book/sh-0.50 P/B- EPS next Y- ROA-201.34% Target Price10.00 Perf Year-46.03%
Cash/sh0.08 P/C49.31 EPS next 5Y- ROE- 52W Range3.09 - 23.43 Perf YTD-13.39%
Dividend- P/FCF- EPS past 5Y0.00% ROI-1087.78% 52W High-82.89% Beta-1.81
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin-214.56% 52W Low29.77% ATR0.28
Employees22 Current Ratio0.65 Sales Q/Q- Oper. Margin-8521.36% RSI (14)61.67 Volatility9.72% 6.65%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin-7170.87% Rel Volume0.95 Prev Close3.99
ShortableYes LT Debt/Eq- EarningsApr 22 Payout- Avg Volume260.69K Price4.01
Recom2.50 SMA2015.70% SMA504.63% SMA200-14.05% Volume247,451 Change0.50%
22-May-13 08:30AM  Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference PR Newswire
20-May-13 09:20AM  BRIEF-Rosetta Genomics up 11.8 percent in premarket trade at Reuters +10.88%
08:35AM  InPlay: Rosetta Genomics announces credentialing agreement with Prime Health Services for miRview mets2 Briefing.com
08:30AM  Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2 PR Newswire
10-May-13 08:33AM  InPlay: Rosetta Genomics announces receipt of $625,000 as payment in full from the negotiated settlement announced on April 18, 2013 with Sanra Laboratories in connection with the co's sale to Sanra of Parkway Clinical Laboratories Briefing.com
08:30AM  Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories PR Newswire
07-May-13 08:30AM  Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting PR Newswire
18-Apr-13 09:02AM  InPlay: Rosetta Genomics reaches settlement agreement with Sanra Laboratories in connection with previous sale of Parkway Clinical Laboratories Briefing.com
09:00AM  Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories PR Newswire
10-Apr-13 10:00AM  Rosetta Genomics Business Update Call scheduled for 10:00 am ET today CCBN
07:34AM  Rosetta Genomics Business Update Call scheduled for 10:00 am ET today CCBN
02-Apr-13 02:36PM  4 Health Care Stocks Under $10 to Watch at TheStreet
09:56AM  Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013 PR Newswire
01-Apr-13 04:03PM  4 Healthcare Stock Stories Prescribed for Investors at Wall St. Cheat Sheet
08:02AM  InPlay: Rosetta Genomics announces acceptance for publication of kidney cancer microRNA diagnostic manuscript by molecular oncology Briefing.com
08:00AM  Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology PR Newswire
29-Mar-13 01:04PM  ROSETTA GENOMICS LTD. Financials EDGAR Online Financials
25-Mar-13 08:30AM  Rosetta Genomics To Host Business Update Conference Call on April 10, 2013 PR Newswire
20-Mar-13 12:18AM  Rosetta Genomics' CEO Presents at 25th Annual ROTH Conference - Transcript at Seeking Alpha
18-Mar-13 09:36AM  InPlay: Rosetta Genomics receives 25th U.S. patent allowance; award strengthens growing portfolio of microRNAs in viral infection Briefing.com
08:32AM  Rosetta Genomics receives U.S. patent allowance at theflyonthewall.com
08:30AM  Rosetta Genomics Receives 25th U.S. Patent Allowance PR Newswire
12-Mar-13 09:12AM  Rosetta Genomics to Present at the 25th Annual Roth Conference PR Newswire
07-Mar-13 12:48PM  Monsanto Acquires Rosetta Green Zacks
20-Feb-13 08:20AM  Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success Marketwire
14-Feb-13 02:54PM  4 Healthcare Stock Stories Prescribed for Investors at Wall St. Cheat Sheet
08:34AM  InPlay: Rosetta Genomics receives two U.S. patent allowances; protects composition of matter and sequencing variants core to its microrna-based molecular diagnostics Briefing.com
08:32AM  Rosetta Genomics receives two U.S. patent allowances at theflyonthewall.com
08:30AM  Rosetta Genomics Receives Two Key U.S. Patent Allowances PR Newswire
07-Feb-13 01:24PM  5 Stocks Under $10 Ready to Soar Higher at TheStreet
09:10AM  InPlay: Rosetta Genomics: study validating ability of microRNAs to predict progression of bladder cancer published in British Journal of Urology International Briefing.com
09:00AM  Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International PR Newswire
05-Feb-13 02:19PM  3 Stocks Under $5 Making Big Moves at TheStreet
30-Jan-13 09:42AM  Rosetta Genomics to be Featured on The Balancing Act® Airing on Lifetime Television Network PR Newswire
10-Jan-13 06:03PM  Nasdaq stocks posting largest percentage increases AP
01:55PM  Nasdaq stocks posting largest percentage increases AP
09:00AM  Top Stocks on the Move: Rosetta Genomics Ltd., Canadian Solar Inc., Interactive Intelligence Group Inc., and Paragon Shipping Inc. PR Newswire
09-Jan-13 06:28PM  Nasdaq stocks posting largest percentage increases AP +14.35%
05:27PM  4 Healthcare Stocks for Investors to Check Out at Wall St. Cheat Sheet
01:27PM  Nasdaq stocks posting largest percentage increases AP
10:10AM  Rosetta Genomics surges after announcing study publication theflyonthewall.com
09:00AM  BRIEF-Rosetta Genomics up in premarket after tumor study data at Reuters
08:34AM  InPlay: Rosetta Genomics reports peer journal publication demonstrating that miRview mets2 assay showed agreement with pathological and clinical information in 92% of cases Briefing.com
08:30AM  Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis PR Newswire
04-Jan-13 08:30AM  Rosetta Genomics to Present at Sidoti & Company 2013 Micro-Cap Conference PR Newswire
07-Dec-12 04:13PM  Rosetta Genomics files $75M mixed securities shelf at theflyonthewall.com
26-Nov-12 08:16AM  Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha +6.64%
23-Nov-12 12:45PM  7 Stocks Under $10 Making Large Upside Moves at TheStreet +12.88%
21-Nov-12 01:22PM  Why I Think Rosetta Genomics Will See $20 In 1-2 Years at Seeking Alpha
15-Nov-12 09:15AM  Rosetta Genomics Added to Ocean Tomo 300 Patent Index PR Newswire
08-Nov-12 09:00AM  Rosetta Genomics to Appoint Dr. Yitzhak Peterburg to its Board of Directors PR Newswire
07-Nov-12 08:28AM  Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha -8.33%
08:20AM  FDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical Trials Marketwire
06-Nov-12 09:07AM  InPlay: Rosetta Genomics: New York State Grants final approval for miRview lung; expands access for co's microRNA diagnostic for identification of four major subtypes of lung cancer Briefing.com +17.29%
09:00AM  New York State Grants Final Approval for miRview® lung; Expands Access for Rosetta Genomics' microRNA Diagnostic for Identification of Four Major Subtypes of Lung Cancer PR Newswire
12-Oct-12 08:49AM  Healthcare Business Rewind: Quest Cuts Management Layers, Intercepts Successful IPO at Wall St. Cheat Sheet
11-Oct-12 06:15PM  Healthcare Business Rewind: Quest Cuts Management Layers, Intercepts Successful IPO at Wall St. Cheat Sheet +5.11%
01:32PM  Nasdaq stocks posting largest percentage increases AP
12:36PM  PropThink: New Leadership Positions Prompt Rally in ROSG Thomson Reuters ONE
09:49AM  InPlay: Rosetta Genomics announced that E. Robert Wassman and Dganit Bar will join the co as Chief Medical Officer and Chief Scientific Officer, respectively, as of Oct 22, 2012 Briefing.com
09:46AM  Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer Marketwire
08-Oct-12 08:32AM  Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire
08:20AM  Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire
03-Oct-12 07:46AM  Healthcare Business Review: Celgene Trial Meets Endpoints, Rosettas Commercial Intro at Wall St. Cheat Sheet -6.23%
05:02AM  Healthcare Business Review: Celgene Trial Meets Endpoints, Rosettas Commercial Intro at Wall St. Cheat Sheet
02-Oct-12 09:08PM  Investor Wants Obagi To Put Itself Up For Sale and 4 Other Stocks On The Move at Wall St. Cheat Sheet -6.29%
06:45PM  Healthcare Business Review: Celgene Trial Meets Endpoints, Rosettas Commercial Intro at Wall St. Cheat Sheet
05:18PM  Investor Wants Obagi To Put Itself Up For Sale and 4 Other Stocks On The Move at Wall St. Cheat Sheet
01:54PM  Rosetta Genomics' CEO Hosts Business Update Conference (Transcript) at Seeking Alpha
01:24PM  Nasdaq stocks posting largest percentage decreases AP
12:04PM  Toyota Teams Up with Microsoft and 4 Hot Stocks Seeing Action at Wall St. Cheat Sheet
10:00AM  Rosetta Genomics Ltd. Business Update Call scheduled for 10:00 am ET today CCBN
08:30AM  Rosetta Genomics and Precision Therapeutics Announce U.S. Commercial Launch of miRview® mets2 PR Newswire
07:35AM  Rosetta Genomics Ltd. Business Update Call scheduled for 10:00 am ET today CCBN
01-Oct-12 06:06PM  Nasdaq stocks posting largest percentage decreases AP -7.09%
01:17PM  Nasdaq stocks posting largest percentage decreases AP
27-Sep-12 01:30PM  5 Stocks Under $10 Set to Soar at TheStreet
25-Sep-12 12:41PM  4 bullish charts to watch at MarketWatch
20-Sep-12 09:52AM  A Pullback Would Be Healthy For Repros Therapeutics at Seeking Alpha
08:00AM  Rosetta Genomics to Present at the 2012 Aegis Healthcare Conference Marketwire
18-Sep-12 02:22PM  3 Stocks Under $10 Making Big Moves at TheStreet +5.00%
01:17PM  Nasdaq stocks posting largest percentage increases AP
09:45AM  Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha
08:22AM  Healthcare Business Recap: Vivuss New Drug Available, Rosetta Shares Pop at Wall St. Cheat Sheet
17-Sep-12 08:28PM  Healthcare Business Review: Vivus New Drug Available, Rosetta Shares Pop at Wall St. Cheat Sheet +17.42%
06:02PM  Nasdaq stocks posting largest percentage increases AP
05:57PM  Healthcare Business Review: Vivus New Drug Available, Rosetta Shares Pop at Wall St. Cheat Sheet
04:19PM  Rosetta Genomics jumps ahead of business update at MarketWatch
08:30AM  Rosetta Genomics to Host Business Update Conference Call on October 2, 2012 Marketwire
10-Sep-12 08:20AM  Faster Approval Process Contributing to Biotech Industry's Success in 2012 Marketwire
02:21AM  Faster Approval Process Contributing to Biotech Industry's Success in 2012 Marketwire
06-Sep-12 05:43PM  Why Rosetta Genomics Is Deeply Undervalued at Seeking Alpha
04-Sep-12 11:58AM  3 Stocks To Consider In Molecular Diagnostics at Seeking Alpha
31-Aug-12 12:33PM  PropThink: Genetic Technologies' Wednesday Gains Unsustainable, Declining Without Momentum Thomson Reuters ONE
30-Aug-12 06:02PM  Nasdaq stocks posting largest percentage decreases AP
01:18PM  Nasdaq stocks posting largest percentage decreases AP
29-Aug-12 06:02PM  Nasdaq stocks posting largest percentage decreases AP -7.31%
04:45PM  Health Care Sector Wrap at Fox Business
12:00PM  Rosetta Genomics Announces Exercise and Closing of Underwriter's Over-Allotment Option PR Newswire
27-Aug-12 06:08PM  Nasdaq stocks posting largest percentage decreases AP
Rosetta Genomics Ltd. develops and commercializes a range of microRNA-based diagnostic tools. MicroRNAs are a group of genes that are produced using instructions encoded in DNA. The company offers diagnostic tests, including miRview mets2, a microRNA-based diagnostic to identify 42 tumor types that include carcinomas, soft tissue tumors, lymphoma, and other malignancies; miRview meso to differentiate mesothelioma, a cancer connected to asbestos exposure and other risk factors, from other carcinomas in the lung and pleura; miRview lung, a lung cancer classification test for cytology samples; and miRview kidney, a microRNA-based kidney tumor classification test for pathology samples. It also distributes miRview mets for identification of the origin of the primary tumor of metastases; and miRview squamous for differentiating squamous from non squamous non-small cell lung cancer. The company also focuses on developing blood-based microRNA biomarkers in order to develop a new diagnostic test for early diagnosis and refined risk stratification of patients following myocardial infarction. It distributes its products primarily in Australia, Canada, Greece, India, Israel, New Zealand, Qatar, Saudi Arabia, Singapore, Turkey, and the United Arab Emirates. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.